Diabetes Flashcards
What drugs are in this class:
Biguanide
Metformin
What drugs are in this class:
Sulfonylureas
Glimepiride
Glipizide
Glyburide
What drugs are in this class:
Meglitinides
Nateglinide
Repaglinide
What drugs are in this class:
Thiaxolidinediones (TZD)
Pioglitazone
Rosiglitazone
What drugs are in this class:
Dipeptidyl peptidase-4 (DPP-4)
Alogliptin
Linagliptin
Saxagliptin
Sitagliptin
What drugs are in this class:
Sodium-glucose co-transporter 2 (SGLT-2) inhibitors
Canagliflozin
Dapagliflozin
Empagliflozin
What drugs are in this class:
Alpha-glucosidase inhibitors
Acarbose
Miglitol
What drugs are in this class:
Glucagon-like peptide-1 (GLP-1) agonists
Albiglutide Dulaglutide Exenatide Exenatide ER Liraglutide Lixisenatide
What drugs are in this class:
Amylin mimetic
Pramlinitide
Brand name(s) for Metformin
Glucophage, Riomet
ER: Glucophage XR, Glumetza, Fortamet
Brand name(s) for Glimepiride
Amaryl
Brand name(s) for Glipizide
Glucotrol
Glucotrol XL
Brand name(s) for Glyburide
Diabeta
Micronase
Brand name(s) for Glyburide, micronized
Glynase
Brand name(s) for Nateglinide
Starlix
Brand name(s) for Repaglinide
Prandin
Brand name(s) for Pioglitazone
Actos
Brand name(s) for Rosiglitazone
Avandia
Brand name(s) for Alogliptin
Nesina
Brand name(s) for Linagliptin
Tradjenta
Brand name(s) for Saxagliptin
Onglyza
Brand name(s) for Sitagliptin
Januvia
Brand name(s) for Canagliflozin
Invokana
Brand name(s) for Dapagliflozin
Farxiga
Brand name(s) for Empagliflozin
Jardiance
Brand name(s) for Acarbose
Precose
Brand name(s) for Miglitol
Glyset
Brand name(s) for Albiglutide
Tanzeum
Brand name(s) for Dulaglutide
Trulicity
Brand name(s) for Exenatide
Byetta
Brand name(s) for Exenatide ER
Bydureon
Brand name(s) for Liraglutide
Victoza
Brand name(s) for Lixisenatide
Adlyxin
Brand name(s) for Pramlintide
SymlinPen
Daily dose for
Metformin
500mg QD - 1000mg BID
Daily dose for
Glimepiride
1-8 mg QD
Daily dose for
Glipizide
5-40 mg QD
Daily dose for
Glyburide
1.25-20 mg daily dosed QD or BID
Daily dose for
Glyburide,, micronized
1.5-12 mg QD
Daily dose for
Nateglinide
60-120 mg before each meal
Daily dose for
Repaglinide
0.5-4 mg before each meal
Max of 16 mg/d
Daily dose for
Pioglitazone
15-45 mg QD
Daily dose for
Rosiglitazone
4-8 mg QD
2-4 mg BID
Daily dose for
Alogliptin
25 mg QD
Daily dose for
Linagliptin
5 mg QD
Daily dose for
Saxagliptin
5 mg QD
Daily dose for
Sitagliptin
100 mg po QD
Daily dose for
Canagliflozin
100-300 mg QD
Daily dose for
Dapagliflozin
5-10 mg QD
Daily dose for
Empagliflozin
10-25 mg QD
Daily dose for
Acarbose
50-100 mg TID
Daily dose for
Miglitol
25-100 mg TID
Daily dose for
Albiglutide
30-50 mg SQ weekly
Daily dose for
Dulaglutide
0.75-1.5 mg SQ weekly
Daily dose for
Exenatide
5-10 mg SQ BID
Daily dose for
Exenatide ER
2mg SQ weekly
Daily dose for
Liraglutide
0.6-1.8 mg SQ daily
Daily dose for
Lixisenatide
10-20 mg SQ daily
Daily dose for
Pramlintide
Type 1 DM: 15-60 mcg TID before meals
Type 2 DM: 60-120 mcg TID before meals
How is this class effective in the treatment of DM Biguanides
Decrease hepatic glucose production
Increase glucose uptake in peripheral tissue
Decrease intestinal glucose absorption
How is this class effective in the treatment of DM Sulfonylureas
Increase insulin secretion
Decrease hepatic glucose production
How is this class effective in the treatment of DM Meglitinides
Increase insulin secretion
Decrease hepatic glucose production
How is this class effective in the treatment of DM Thiaxolidinediones
Increase insulin sensitivity
Decrease hepatic glucose production
How is this class effective in the treatment of DM Dipeptidyl peptidase-4 (DPP-4) inhibitors
Decrease breakdown of endogenous GLP-1
How is this class effective in the treatment of DM Sodium-glucose co-transporter 2 (SGLT-2) inhibitors
Inhibits SGLT-2
Increases urinary glucose excretion
How is this class effective in the treatment of DM Alpha-glucosidase inhibitors
Delay digestion of carbohydrates
How is this class effective in the treatment of DM Glucagon-like peptide-1 (GLP-1) agonists
Stimulate GLP-1 receptors resulting in GLUCOSE-DEPENDENT insulin secretion
Decreased postprandial glucagon secretion
Decreased gastric emptying rate
Early satiety
How is this class effective in the treatment of DM Amylin mimetic
Amylin analog resulting in
Decreased postprandial glucagon secretion
Decreased gastric emptying rate, early satiety
Common side effects of
Biguanide
Diarrhea
N/V
Abdominal pain/bloating
Low B12
Common side effects of
Sulfonylureas
Hypoglycemia
Weight gain
Common side effects of
Meglitinides
Hypoglycemia
Weight gain
Common side effects of
Thiazolidinediones
Weight gain
Edema
Common side effects of
Dipeptidyl peptidase-4 (DPP-4) inhibitors
Nasopharyngitis
Upper respiratory tract infections
HA
UTI
Common side effects of
Sodium-glucose co-transporter 2 (SGLT-2) inhibitors
Hypotension Dehydration Weight loss Genital mycotic infections UTI Hyperkalemia (canagliflozin) Increase in LDLs Increased hematocrit (dapa, empa)
Common side effects of
Alpha-glucosidase inhibitors
Flatulence GI upset Abdominal pain/bloating Diarrhea Increase in LFTs and bilirubin
Common side effects of
Glucagon-like peptide-1 (GLP-1) agonists
N/V/D
HA
Weight loss
Common side effects of
Amylin mimetics
Hypoglycemia
N/V/D
HA
Anorexia
Contraindications of
Biguanide
eGFR < 30
Unstable, symptomatic HF
Hepatic impairment
Contraindications of
Sulfonylureas
Caution in elderly patients
Avoid use of glyburide b/c of increased risk of hypoglycemia
Contraindications of
Meglitinides
Do not administer repaglinide with gemfibrozil
Contraindications of
Thiazolidinediones
Bladder cancer (pioglitazone) HF Hepatic impairment Ischemic heart disease MI (rosiglitazone) Risk of bone fracture
Contraindications of
Dipeptidyl peptidase-4 (DPP-4) inhibitors
Pancreatitis
Contraindications of
Sodium-glucose co-transporter 2 (SGLT-2) inhibitors
Canagliflozin - eGFR <45
Empagliflozin - eGFR <45
Dapagliflozin - eGFR <60
Contraindications of
Alpha-glucosidase inhibitors
Inflammatory Bowel Disease (IBD) Ulcerative colitis Crohn's disease Partial intestinal obstruction Short bowel syndrome Renal impairment (SCr >2 or CrCl < 25)
Contraindications of
Glucagon-like peptide-1 (GLP-1) agonists
Gastroparesis
Pancreatitis
Multiple endocrine neoplasia syndrome type 2
Personal or family history of medullary thyroid carcinoma
Contraindications of
Amylin mimetics
Severe, recurrent hypoglycemia Hypoglycemic unawareness Gastroparesis ESRD Poor adherence to insulin regimen Poor adherence to self-monitoring blood glucose
True/False
You can cut/crush/chew metformin ER
False
Sulfonylureas have a long/short duration of action? Why is this important?
Long
Patients need to eat in regular intervals to avoid hypoglycemic episodes
Which have a longer duration of action sulfonylureas or meglintinides
Sulfonylureas
True/False
If you skip a meal you should skip your dose of Meglitinide
True
Can you use Meglitinides and Sulfonylureas together? Why?
No!
They both increase insulin release so this can lead to hypoglycemia
Which thiazolidinedioine (TZD) needs to be dispensed with a medication guide?
Rosiglitazone
Dose adjustment for DPP-4 inhibitors
Saxagliptin (Onglyza): CrCl <50 - 2.5 mg/d
Sitagliptin (Januvia): CrCl 30-50 - 50 mg/d; CrCl <30 - 25 mg/d
Which DPP-4 does NOT need a dose adjustment?
Linagliptin (Tradjenta)
What pt populations should SGLT-2 inhibitors be used with caution
Pts taking diuretics and elderly
True or False
Alpha-glucosidase inhibitors are recommended for use by the ADA
False
Dose adjustment GLP-1 agonists
Albiglutide , Dulaglutide (Trulicity), Liraglutide (Victoza): no adjustment necessary
Exenatide (Byetta): CI CrCl <30
Lixisenatide (Adlyxin): CI CrCl<15
When initiating an amylin mimetic, how much should you reduce mealtime insulin by and why?
50% to avoid hypoglycemia